Results 31 to 40 of about 14,396 (200)
Evaluating the in vitro activity of cefoperazone-sulbactam against Gram negative pathogens in blood stream infections using automated systems [PDF]
Iranian Journal of MicrobiologyBackground and Objectives: The incidence of multidrug-resistant, Gram-negative organisms, isolated as the etiological agents of infections is ascending.
Uksim Qadri +6 more
doaj +2 more sources
Perioperative antibiotic prophylaxis in surgery
Perioperative Medicine, 2021 Infectious complications in surgery occupy a significant place among the causes of death and increase in the cost of medical care for various pathologies.
Dmytro Dmytriiev +2 more
doaj +1 more source
Frontiers in Medicine, 2021 There has previously been a report of a patient developing haemolytic anaemia following exposure to cefoperazone. Another case has been reported involving the detection of cefoperazone-dependent antibodies in the absence of immune haemolytic anaemia.
Yuanjun Wu +7 more
doaj +1 more source
Retrospective Analysis of Risk Factors for Cefoperazone/Sulbactam-Induced Thrombocytopenia in Adult Chinese Patients: A Six-Year Real-World Study [PDF]
Infection and Drug ResistanceBolin Zhu, Pengfei Jin, Jianchun Li, Yuanchao Zhu Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Assessment of Clinical Drugs Risk ...
Zhu B, Jin P, Li J, Zhu Y
doaj +1 more source
Cefoperazone Induced Gastrointestinal Bleeding [PDF]
Journal of Clinical and Diagnostic Research, 2016 Cefoperazone is a beta-lactam antibiotic which is frequently used in treating a variety of gram positive and gram negative infections. The chemical structure of cefoperazone contains a side chain of N-methylthiotetrazole which can inhibit vitamin K ...
Goutham Reddy Katukuri +3 more
doaj +1 more source
Frontiers in Pharmacology, 2022 Objective: Cefoperazone/sulbactam is a commonly used antibiotic combination against the extended-spectrum beta-lactamases (ESBLs)-producing bacteria. The objective of this study was to evaluate the efficacy of a new cefoperazone/sulbactam combination (3 ...
Xi-Wei Ji +10 more
doaj +1 more source
RATIONAL USE OF 3rd GENERATION CEPHALOSPORINS IN TERTIARY CARE HOSPITALS: A CONCURRENT DUR
International Journal of Pharmacy & Integrated Health Sciences, 2022 Background: Assessment of use of antimicrobials can be performed by evaluating their use. Drug use evaluation is a performance improvement method that concentrates on improvement and evaluation of drug use processes to achieve optimal patient outcomes.
doaj +1 more source
Antibiotics, 2022 Cefoperazone/sulbactam (CPZ/SUL) is a β-lactam and β-lactamase inhibitor combination therapy for the treatment of respiratory tract infections. Using data from a prospective, multiple-center, open-label clinical trial in 54 patients with hospital ...
Yingjie Zhou +9 more
doaj +1 more source
In vitro evaluation of cefoperazone [PDF]
Antimicrobial Agents and Chemotherapy, 1980 The activity of cefoperazone, a new broad-spectrum cephalosporin, was tested in vitro against 670 clinical isolates of gram-negative bacilli and gram-positive cocci. With the exception of Enterobacter spp., it inhibited the majority of all organisms tested at a concentration of 6.25 microgram/ml.
A M, Hinkle, B M, LeBlanc, G P, Bodey
openaire +2 more sources
Antimicrobial Resistance and Infection Control, 2019 Background We retrospectively analyzed the effect of tigecycline and cefoperazone/sulbactam therapies on the prognosis of patients with carbapenem-resistant Acinetobacter baumannii bloodstream infection (CRAB-BSI).
Tianshui Niu +5 more
doaj +1 more source